Skip to search.
 TSX Up 0.13% TSX Ventures Up 0.09%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
66.49 Down 0.44(0.66%) 12:17PM EST - Nasdaq Real Time Price
Prev Close:66.93
Open:67.46
Bid:66.69 x 200
Ask:66.80 x 100
1y Target Est:56.43
Beta:2.32501
Earnings Date:Feb 7 - Feb 13 (Est.)
Day's Range:66.36 - 68.68
52wk Range:26.02 - 75.36
Volume:275,206
Avg Vol (3m):1,211,400
Market Cap:9.41B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENDown 0.66%9.41B
IMGNUp 1.21%167.00M
1 0.00%N/A
PFEUp 2.52%192.49B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.95
Quarterly EPS Est (Dec-16) :-0.34
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-3.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback